Menu
/REGISTER
Montecito
Pac Premier
Loading...
You are here:  Home  >  'traits'
Latest

Amgen paying Arrowhead for traits to develop cardiovascular drugs

By   /  Thursday, September 29th, 2016  /  Central Coast Health Watch, Latest news  /  Comments Off on Amgen paying Arrowhead for traits to develop cardiovascular drugs

Amgen will license two traits from a Pasadena pharmaceutical company to develop cardiovascular drugs under a partnership announced Sept. 29. Under the agreement, Thousand Oaks-based Amgen will pay Arrowhead Pharmaceuticals $35 million up front, $21.5 million in the form of an equity investment by Amgen in Arrowhead common stock, and up to $617 million in Read More →

Read More →
Latest

Investing money in Ceres requires act of blind faith

By   /  Friday, May 6th, 2016  /  Columns, Latest news, Technology  /  Comments Off on Investing money in Ceres requires act of blind faith

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Ceres corn traits do not require USDA oversight

By   /  Thursday, February 18th, 2016  /  Agribusiness, Latest news  /  Comments Off on Ceres corn traits do not require USDA oversight

Thousand Oaks ag-biotech company Ceres said the U.S. Department of Agriculture told the company Feb. 17 that several corn traits Ceres developed do not need to be regulated under a USDA mandate. For years, Ceres developed genetically modified crops for use in biofuels. Last June, the company switched its focus to developing genetically modified crops Read More →

Read More →